C7orf29 Antikörper (AA 131-236) (Biotin)

Produktnummer ABIN1699929

Produktdetails anti-C7orf29 Antikörper (Biotin)

Target: C7orf29 (C7ORF29) (Chromosome 7 Open Reading Frame 29 (C7ORF29))

Bindungsspezifität: AA 131-236

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C7orf29 Antikörper ist konjugiert mit Biotin

Applikation: ELISA, Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C7ORF29

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu C7orf29

Target: C7orf29 (C7ORF29) (Chromosome 7 Open Reading Frame 29 (C7ORF29))

Andere Bezeichnung: C7ORF29 (C7ORF29 Produkte)

Synonyme: C7orf29 antikoerper, ZBED6 C-terminal like antikoerper, ZBED6CL antikoerper

Hintergrund:

Synonyms: C7orf29, CG029_HUMAN, Chromosome 7 open reading frame 29, Hypothetical protein LOC113763, Uncharacterized protein C7orf29.

Background: Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf29 gene product has been provisionally designated C7orf29 pending further characterization.

Gen-ID: 113763